Renal Transplantation Could Reverse Dialysis-Associated Porphyria
Open Access
- 27 August 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28482
Abstract
Pseudoporphyria (PP) is a relatively infrequent, photodistributed bullous dermatosis that clinically, histopathologically, and immunologically resembles porphyria cutanea tarda (PCT), but is not accompanied by porphyrin abnormalities in the serum, urine, or stool. It was initially described in patients with renal failure on dialysis as 'bullous dermatosis of hemodialysis.' Pseudoporphyria has been seen in patients with end-stage renal disease on hemodialysis. No treatment has proved efficacious in the management of pseudoporphyria. However, N-acetylcysteine has been anecdotally reported to be effective in the management of hemodialysis-related pseudoporphyria and other porphyric diseases. Our patient had developed multiple skin lesions all over the body when hemodialysis started. The lesions were erythematous with fluid-filled vesicles, and bullae with cutaneous fragility that were evaluated and diagnosed as pseudoporphyria. The patient was treated with available all medication in the literature but was not relieved. However, all skin lesions completely healed within 22 days post renal transplantation. Renal transplantation proved to be the cure for dialysis-induced pseudoporphyria resistant to conventional drug therapy.Keywords
This publication has 13 references indexed in Scilit:
- Pseudoporphyria Associated with Nonhemodialyzed Renal Insufficiency, Successfully Treated with Oral N-AcetylcysteineCase Reports in Dermatological Medicine, 2013
- PorphyriasThe Lancet, 2010
- Dermatologic Conditions Seen in End‐Stage Renal DiseaseSeminars in Dialysis, 2009
- Successful Outcome of Haemodialysis-induced Pseudoporphyria after Short-term Oral N-Acetylcysteine and Switch to High-flux Technique DialysisActa Dermato-Venereologica, 2006
- Pseudoporphyria associated with hemodialysis treated with N-acetylcysteine*Journal of the American Academy of Dermatology, 2003
- Pseudoporphyria: a clinical and biochemical study of 20 patientsMayo Clinic Proceedings, 2001
- PseudoporphyriaJournal of the American Academy of Dermatology, 2001
- Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two casesBritish Journal of Dermatology, 2000
- Porphyria cutanea tarda in a human immunodeficiency virus‐infected patient: treatment with N‐acetyl‐cysteineInternational Journal of Dermatology, 1998
- Cysteine Ameliorates Photosensitivity in Erythropoietic ProtoporphyriaArchives of Dermatology, 1993